Chiesi Farmaceutici Spa
🇮🇹Italy
- Country
- 🇮🇹Italy
- Ownership
- Subsidiary
- Established
- 1935-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.chiesi.com
Clinical Trials
33
Active:33
Completed:0
Trial Phases
1 Phases
Phase 1:12
Drug Approvals
4
NMPA:2
EMA:2
Drug Approvals
Beclometasone Dipropionate and Formoterol Inhalation Aerosol
- Product Name
- 倍氯米松福莫特罗吸入气雾剂
- Approval Number
- 国药准字HJ20181177
- Approval Date
- Dec 16, 2022
NMPA
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 1
12 (100.0%)No trials found
News
No news found